LINDSAY DUFRESNE: Open Payments
NPI 1346855715 · THIBODAUX, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,118 in 56 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,118
Food & beverage: $978Education: $139
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $402 |
| GENZYME CORPORATION | 7 | $198 |
| Janssen Biotech, Inc. | 5 | $146 |
| Regeneron Healthcare Solutions, Inc. | 2 | $101 |
| Organon LLC | 3 | $95 |
| Amgen Inc. | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Incyte Corporation | 1 | $27 |
| UCB, Inc. | 1 | $25 |
| LEO Pharma Inc. | 1 | $21 |
Products named: DUPIXENT, SKYRIZI, RINVOQ, TREMFYA, VTAMA, OTEZLA, Sotyktu, OPZELURA.
Industry payments across LA — which companies pay providers there.
